医学
内科学
肌萎缩侧索硬化
铁蛋白
肌酐
胃肠病学
甘油三酯
内分泌学
血清学
体质指数
尿酸
胆固醇
免疫学
疾病
抗体
作者
Ken Ikeda,Takehisa Hirayama,Takanori Takazawa,Kiyokazu Kawabe,Yasuo Iwasaki
出处
期刊:Internal Medicine
[Japanese Society of Internal Medicine]
日期:2012-01-01
卷期号:51 (12): 1501-1508
被引量:153
标识
DOI:10.2169/internalmedicine.51.7465
摘要
Objective Previous studies have reported distinct serological profiles of lipid, urate and ferritin in Western patients with amyotrophic lateral sclerosis (ALS). We aimed to examine the levels of these serological factors and their relationship to disease progression in Japanese ALS patients. Methods Ninety-two patients with definite or probable ALS who fulfilled the revised El Escorial criteria were analyzed for clinical and serological variables. Serological data at the time diagnosed with ALS were compared to those of 92 age/sex/body mass index-matched healthy controls. Results Compared to controls, urate and creatinine (Cr) levels were decreased and ferritin levels were increased significantly in sera of male and female patients with ALS. Significant increases of serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and triglyceride levels were found in female ALS patients. The annual decline of ALS Functional Rating Scale-Revised (ALS-FRS) and forced vital capacity (FVC) were inversely correlated with serum TC, LDL-C, Cr and urate levels, and were positively correlated with serum ferritin levels. Multivariate analysis showed that the rapid worsening of annual ALS-FRS and FVC was associated with serum levels of TC, LDL-C, Cr, urate and ferritin. Conclusion The present study indicated that serum levels of TC, LDL-C, Cr, urate and ferritin were correlated with clinical deterioration in ALS patients. These results are similar to those in Western patients. Metabolic and nutritional conditions of lipid, urate and iron could contribute to disease progression in ALS patients. Further studies investigating high nutrition diets and iron chelation for the treatment of ALS are warranted.
科研通智能强力驱动
Strongly Powered by AbleSci AI